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Abstract 
 
This study demonstrates the feasibility of using quantitative real time PCR to 
measure genomic bacterial load in the nasopharynx of children with invasive 
meningococcal disease and shows that these loads are exceptionally high (median 
6.6 x 105 (Range 1.2 x 105 to 1.1 x 108) genome copies of Neisseria meningitidis per 
swab). 
 
Abstract
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Introduction 
Invasive infection with Neisseria meningitidis (NM) causes meningitis and septicemia 
in children [meningococcal disease]. Most adults have carried meningococcus in 
their nasopharynx at some stage during their lives1 and most remain asymptomatic. 
A very small proportion progress to invasive disease. 
The prevalence of meningococcal carriage is often quoted as being ~10%, although 
it should be emphasised this refers to the average carriage rate across all age 
groups.2 Carriage rates vary dramatically with age, with the lowest rates seen in very 
young children, who are at highest risk of invasive disease, and the highest rates 
(often in excess of 20%) seen in late adolescence.2,3 
Public Health England (PHE) and National Institute for Health and Care Excellence 
(NICE) guidelines previously disagreed over the value of nasopharyngeal specimens 
as a diagnostic test for this infection. PHE recommend that testing of 
nasopharyngeal specimens may help support a clinical diagnosis alongside other 
signs and symptoms, and can allow identification of strains in the event of a cluster 
or outbreak.2 Advice not to test nasopharyngeal specimens by any method because 
of the risk of detecting asymptomatic carriage has recently been removed from UK 
NICE guidance, to bring it into line with PHE guidance.5  
Two previous studies from our group demonstrate that molecular testing of nasal and 
throat swabs has a sensitivity of 81 to 84 % and a specificity of 100% as a diagnostic 
test for meningococcal disease.6,7 With the recent development and licensure of 
novel meningococcal vaccines, their effect on reducing nasopharyngeal carriage is 
likely to have a major impact on their effectiveness at inducing herd protection. 
Manuscript
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Two studies demonstrate a strong association between meningococcal DNA load in 
blood at presentation and disease severity.8,9 To date, no study has attempted to 
quantify meningococcal DNA load in nasopharyngeal specimens using molecular 
testing.  
Estimation of nasopharyngeal bacterial load is complicated by potential 
inconsistency in the sampling technique resulting in varying amounts of cellular 
material being obtained. Specifically, false negative results may arise from poor 
quality specimens containing little or no cellular material. The RNAseP gene is a 
proven single copy human gene. Absolute quantification of this gene using real-time 
TaqMan PCR can be used to accurately estimate the quantity of human DNA (and 
hence cells) in a clinical sample.10 This enables quality control of specimens, and 
can potentially also be used to ‘normalise’ the bacterial load data. 
The aim of this study was to define the meningococcal DNA load in nasopharyngeal 
specimens in children with meningococcal disease. 
 
Methods 
Nasopharyngeal swabs and blood specimens were collected from children with 
suspected meningococcal disease as part of an ethically approved diagnostic 
accuracy study between November 1st 2009 and January 31st 2012.7 
Nasopharyngeal specimens were obtained using rayon tipped throat swabs 
(Transwab, MWE, Wiltshire, UK) and floc tipped nasal swabs (Copan, Brescia, Italy). 
Both swabs were then placed into a single container containing 1 ml of eNat nucleic 
acid transport medium (Copan, Brescia, Italy). For this study paired samples from 
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children with laboratory confirmed disease [Culture of NM and/or detection of NM 
DNA from a normally sterile site; see reference 7] were analysed. Specimens were 
tested using ctrA and RNAseP real-time TaqMan PCR and the genomic bacterial 
load was estimated using external standard curve calibration. Details of the PCR 
assays, molecular testing protocols and calculation of standard curves is given in 
Supplementary Digital Content A. Requirement for fluid bolus resuscitation was used 
as an indicator of more severe clinical presentation. 
 
Statistical methods 
Skewed data were log transformed for statistical comparisons. Pearson’s correlation 
coefficient and means were compared using an independent samples two tailed t 
test. One obvious and statistically significant outlier {linear regression RStudent >2 
criteria (outlier) and CooksD >0.5 (undue influence)} was not included in the 
analyses but the outlier was separately described. 
Multiple regression analysis was performed using age (in days), gender, severity 
score (with/without fluid bolus) and copy number in blood as variables to predict copy 
number in the nasopharynx. 
 
Results 
21 pairs of specimens from children with laboratory confirmed meningococcal 
disease were analysed. 
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There was a 2:1 female:male ratio (67% female, 33% male). The age range was 6 
months to 8 years 4 months (mean 2 years 10 months). Using need for fluid bolus 
resuscitation as a proxy for severity, 10/21 (48%) required at least one bolus. 
 
The nasopharyngeal specimens contained a median of 6.6 x 105 (Range 1.2 x 105 to 
1.1 x 108) genome copies of meningococcus per ml of transport medium. As the 
combined nasal and throat swab were inserted into 1 ml of medium this reflects the 
total amount of bacteria obtained on both swabs. The blood specimens contained a 
median of 9.9 x 105 (Range 3.7 x 104 to 8.2 x 107) genome copies of meningococcus 
per ml of original specimen. There was no difference in mean log copy number 
between nasopharyngeal and blood specimens (3.49 log10 copies/ml versus 3.54 
log10 copies/ml, p = 0.9).  
The outlier excluded from the analysis was from a patient who had an exceptionally 
high nasopharyngeal bacterial load [1.1 x 108] and a moderate blood bacterial load 
[4.7 x 106] following a short [<6 hours] history. Without this outlier value a moderate 
correlation (R= 0.57 (95% CI: 0.16 to 0.80) [Figure 1]) was found between 
nasopharyngeal and blood meningococcal copy number.  
Analysis of RNAseP in the nasopharyngeal specimens revealed a median of 2.5 x 
105 (range 2.1 x 103 to 6.4 x 106) cells per ml of transport medium. Correcting the 
bacterial load for nasopharyngeal specimen quality by calculating the number of 
bacteria per host cell weakened the correlation between log nasopharyngeal and log 
blood meningococcal copy number. A strong correlation between log bacteria per 10 
cells and the raw log nasopharyngeal copy number was observed (Pearson’s 
correlation coefficient R= 0.74, p =0.001) indicating that the uncorrected and 
corrected nasopharyngeal load are closely related.  
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Children who required fluid resuscitation at the time of admission had significantly 
higher mean blood log copy numbers than those who did not (3.90 log10 copies/ml 
versus 3.06 log10 copies/ml, p = 0.02). Nasopharyngeal log copy number also tended 
to be higher but this did not reach significance. The single patient who died during 
the study had a nasopharyngeal meningococcal copy number of 5.1 x 106 (seven 
times higher than the median) and a blood meningococcal copy number of 3.1 x 107 
(thirty times higher than the median). This patient had a short history having gone to 
bed well at 22:00 and awoken in the early hours of the morning with an extensive 
purpuric rash. 
Multiple regression analysis confirmed that copy number in blood was the only 
statistically significant predictor of copy number in the nasopharynx, after adjustment 
for age, gender and severity (β-coefficient 0.84; p=0.024). None of the other 
variables were significant, and there was no bias towards more severe clinical 
presentation. 
 
Discussion 
This small study is the first to demonstrate the exceptionally high nasopharyngeal 
loads of meningococcus in patients presenting with confirmed meningococcal 
disease. The bacterial load in blood is very similar to previous studies indicating that 
the methodology used is robust.8,9 After removal of one statistical outlier we 
observed a moderate correlation between nasopharyngeal and blood bacterial load. 
This potential correlation is based on a small data set and confirmation in a larger 
study is required.  Multiple regression analysis identified blood load as the only 
statistically significant predictor of nasopharyngeal load. 
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Interpretation of meningococcal load in nasopharyngeal specimens is challenging 
because of potential inconsistency in sampling. Analysis of RNAseP reveals that the 
quantity of human material obtained by a nasopharyngeal swab ranges from a few 
thousand to a few million cells. Despite this variation we still demonstrate very high 
loads, even in relatively poor quality samples. Furthermore, there is a strong 
correlation between the raw meningococcal load data and meningococcal load 
corrected for swab quality indicating that correction is probably not necessary.  
In this study we only had a single specimen at a single time point and cannot 
describe the dynamics of meningococcal copy number or relate nasopharyngeal to 
blood copy number as invasive disease progresses. The demonstration of relatively 
high nasopharyngeal loads in some patients supports our hypothesis that molecular 
testing of nasopharyngeal specimens adds value to diagnostic testing for 
meningococcal disease. Testing of both nasopharyngeal and blood specimen by ctrA 
real-time TaqMan PCR (as occurs in our unit) has the potential to capture more 
cases. Using a molecular test to detect the ctrA gene in nasopharyngeal swabs 
ensures that only pathogenic (capsular) strains are detected. In contrast, culture of 
nasopharyngeal swabs will also recover carrier (acapsular) strains. 
Novel meningococcal B vaccines targeting outer membrane vesicles may have a 
much less dramatic effect on carriage11 than conjugate vaccines like Men C which 
virtually eliminated carriage. It is clear that any large implementation programme will 
require careful monitoring of carriage and we believe that the methodology described 
in this study would be ideal for large scale accurate surveillance studies. 
The results presented here confirms that quantitative data can be reliably obtained 
from nasopharyngeal swab specimens using molecular methods, and that a human 
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gene target (RNAseP) can be used as an endogenous control. These data provide 
further evidence that molecular testing of respiratory specimens is feasible, and may 
give diagnostically useful information in suspected meningococcal disease. We 
believe that access to relatively non-invasive rapid molecular testing of 
nasopharyngeal specimens such as meningococcal LAMP 7,12 has potential to 
increase diagnosis of meningococcal disease in the early stages where 
nasopharyngeal loads may to be relatively higher as initial replication is taking place. 
 
Conflicts of interest and relevant funding: 
TWB received a grant from the Health & Social Care Research and Development 
Office, Public Health Agency, Northern Ireland. JPM, PVC and DJF hold share 
options in Hibergene Diagnostics Ltd. JPM, PVC and DJF hold patent US 8465927 
B2 related to the meningococcal LAMP assays cited in this study which is licensed to 
Hibergene Diagnostics Ltd. MDS has nothing to disclose.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
 
References 
 
1. Caugant DA, Maiden MC. Meningococcal carriage and disease-population 
biology and evolution. Vaccine. 2009;27 Suppl 2: B64-70. 
2. Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: 
nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidem. 
Inf. 1987; 99:591-601 
3. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal 
carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 
2010; 10:853-61 
4. Health Protection Agency Meningococcus and Haemophilus Forum. 2012. 
Guidance for public health management of meningococcal disease in the UK. 
https://www.gov.uk/government/publications/meningococcal-disease-
guidance-on-public-health-management accessed March 15th, 2015. 
5. National Institute for Health and Care Excellence. 2010. NICE Guidance 
CG102: Bacterial meningitis and meningococcal septicemia: Management of 
bacterial meningitis and meningococcal septicemia in children and young 
people younger than 16 years in primary and secondary care. 
https://www.nice.org.uk/guidance/cg102  accessed March 15th, 2015. 
6. Dunlop K, Coyle, P, Mitchell S et al. Molecular testing of respiratory swabs 
aids early recognition of meningococcal disease in children. Diagn Microbiol 
Infect Dis. 2011; 70: 427–34. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
7. Bourke T, McKenna J, Coyle P, Shields M, Fairley D. Diagnostic accuracy of 
‘loop mediated isothermal amplification’ (LAMP) as a near-patient test for 
meningococcal disease in children; an observational cohort study. Lancet 
Infect Dis. 2015; 15(5):552-8 
8. Hackett SJ, Guiver M, Marsh J et al. Meningococcal bacterial DNA load at 
presentation correlates with disease severity. Arch Dis Child. 2002;86:44-46. 
9. Darton T, Guiver M, Naylor S et al. Severity of meningococcal disease 
associated with genomic bacterial load. Clin Infect dis. 2009;48:587-594 
10. McNees AL, White Z, Zanwar P, Vilchez  R, Butel J. Specific and quantitative 
detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J 
Clin Virol. 2005;34:52–62. 
11. Bettinger JA, Deeks SL, Halperin SA, Tsang R, Scheifele DW. Controlling 
serogroup B invasive meningococcal disease: the Canadian perspective. 
Expert Rev Vaccines. 2013; 12(5):505-17 
12. McKenna JP, Fairley DJ, Shields MD et al. Development and clinical 
validation of a loop-mediated isothermal amplification method for the rapid 
detection of Neisseria meningitidis. Diagn Microbiol Infect Dis. 2011;69:137–
44. 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
 
Figure 1. Comparison of Neisseria meningitidis genome copy number in 
nasopharyngeal  and blood specimens  1  2 
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Supplementary digital content A 
DNA Extraction 
DNA was extracted from EDTA blood (200μl) and eNat medium (200μl, containing 
combined nasal and throat swabs) using a QuickGene Mini80 system and DB-S 
DNA kit (Fuji Corporation, Tokyo, Japan) according the manufacturers’ instructions.  
Standard curves 
Standard curves were defined for absolute quantification using real-time TaqMan 
PCR. Neisseria meningitidis serogroup B (NCTC 10026) was cultured, suspended in 
saline and subjected to DNA extraction using QIAamp DNA Mini Kit. The genomic 
DNA in the extract was quantified using a NanoDrop spectrophotometer (NanoDrop 
Products, Wilmington, USA). The number of copies of meningococcal DNA per ml of 
extract was then estimated from the average genomic molecular weight of 
meningococcus B.1 For the RNAseP target 200 µl of sterile EDTA blood (male) was 
extracted using the same extraction method. The genomic DNA in the extract was 
quantified using a NanoDrop. The number of human genome copies was estimated 
from the average molecular weight of the haploid human genome (6.294 × 109 base 
pairs).2 Tenfold serial dilutions of the meningococcal and human DNA extracts were 
then prepared and tested by ctrA and RNAseP real-time TaqMan PCR respectively 
[see below]. Standard curves were constructed using “trimmed mean” values from 5 
replicates (mean of 3 central results from each replicate set). This gives a more 
robust measure of central tendency than the arithmetic mean.3 
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PCR assays 
PCR assays used Invitrogen Platinum® Quantitative PCR SuperMix-UDG (Life 
Technologies Ltd., Paisley, UK).  Primers and a TaqMan® probe to detect the 
meningococcal ctrA gene were used as described previously.4 An additional reverse 
primer (5'-TTGCCGCGGATTGGCCACCA-3') was used5 to ensure that strains with 
known mutations in the ctrA gene could be reliably detected.6,7 Primers and probe to 
detect RNAseP were used as described by the Centre for Disease Control, 2009 
[RNAseP F: 5'- AGA TTT GGA CCT GCG AGC G -3'; RNAseP R: 5'- GAG CGG 
CTG TCT CCA CAA GT -3'; RNAseP P: 5'-FAM - TTC TGA CCT GAA GGC TCT 
GCG CG -TAMRA 3'] 
PCR assays were run on a LightCycler® 480II real-time PCR system (Roche 
Diagnostics Ltd., Burgess Hill, UK) using the following thermal cycling protocol: 50°C 
(10 minutes); 95°C (2 minutes); 45 cycles of 95°C (15 seconds) and 60°C (30 
seconds).  
All analysis was conducted on a single plate to avoid inter-assay variation. DNA copy 
number per µl of extract for each specimen was calculated using the standard 
curves. Meningococcal bacterial load per ml of blood and meningococcal load and 
number of human cells per ml of transport medium were than calculated. 
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